You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

Article info

Article menu

Download PDFPDF

XML
Research Article
PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer

Authors

  • Zi-Qi Zhou Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Jing-Jing Zhao Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Qiu-Zhong Pan Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Chang-Long Chen Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Yuan Liu Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Yan Tang Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Qian Zhu Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • De-Sheng Weng Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  • Jian-Chuan Xia Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South ChinaSun Yat-sen University Cancer Center 510060 Guangzhou People’s Republic of China Department of BiotherapySun Yat-sen University Cancer Center Guangzhou China PubMed articlesGoogle scholar articles
  1. ↵h +86-20-87345699 wengdsh{at}sysucc.org.cn
  2. ↵i +86-20-87345699 xiajch{at}mail.sysu.edu.cn
View Full Text

Citation

Zhou Z, Zhao J, Pan Q, et al
PD-L1 expression is a predictive biomarker for CIK cell-based immunotherapy in postoperative patients with breast cancer
Journal for ImmunoTherapy of Cancer 2019;7:228. doi: 10.1186/s40425-019-0696-8

Publication history

  • Received October 14, 2018
  • Accepted July 30, 2019
  • First published August 27, 2019.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.